Correcting CFTR folding defects by small-molecule correctors to cure cystic fibrosis
Open Access
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 34, 83-90
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Foundation
- NWO Graduate School grant
This publication has 58 references indexed in Scilit:
- CFTR: folding, misfolding and correcting the ΔF508 conformational defectTrends in Molecular Medicine, 2012
- Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and FunctionCell, 2012
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved SequencesCell, 2012
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809Proceedings of the National Academy of Sciences of the United States of America, 2011
- Probing Conformational Rescue Induced by a Chemical Corrector of F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) MutantJournal of Biological Chemistry, 2011
- Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis MutationsJournal of Biological Chemistry, 2011
- The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator BiogenesisJournal of Biological Chemistry, 2010
- The V510D Suppressor Mutation Stabilizes ΔF508-CFTR at the Cell SurfaceBiochemistry, 2010
- Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosisNature Chemical Biology, 2009
- Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel functionProceedings of the National Academy of Sciences, 2008